Why is Core Scientific stock up today?

Traders Union
All News
Financial News
Core Scientific rises 6.50% today

Highlights

Core Scientific amended prior financials after its auditor found demolition costs were incorrectly capitalized, though revenue and cash flow remain unchanged.
A material weakness in internal controls will be reported for the next four quarters, spotlighting ongoing governance risks for investors.
Shares face near-term pressure with the price expected to range between $15.78 and $17.26; technical signals favor further downside unless support at $15.87 holds.

Governance scrutiny rises as Core Scientific amends financial filings

Core Scientific recently held its Q4 earnings call, during which it disclosed amendments to previously filed financial statements after its auditor identified demolition costs that had been incorrectly capitalized rather than expensed. The company clarified that these corrections will not impact revenue, adjusted EBITDA, or net cash flow. However, Core Scientific will report a material weakness in internal controls for the coming four quarters, drawing attention to ongoing governance and oversight considerations.

Anton Kharitonov, expert at Traders Union, notes that CORZ is facing mixed technical signals with price still below key short-term averages. He sees ongoing risk from the recent disclosure of a material weakness in internal controls, which could dampen investor confidence and prolong short-term pressure. Momentum indicators remain broadly negative. He points out that volatility is high, but intraday gains do not reverse the dominant selling trend. "Despite a temporary bounce, the weak governance and trend momentum make further downside risk more likely in the near term," Kharitonov warns.

Viktoras Karapetjanc, expert at Traders Union, views the recent correction of historical accounting as a sign of improved transparency and future operational discipline. He believes the company’s swift communication helps strengthen market trust and maintains strategic clarity. Although a material weakness will be reported, forward-looking signals and support above SMA-200 suggest bullish structure remains intact. "I expect Core Scientific to recover lost ground as confidence in management and fundamentals continue to improve," Karapetjanc asserts.

Parshwa Turakhiya, analyst, highlights that CORZ sits at a technical crossroads with oversold indicators and moderate volatility offering possible short-term setups. He notes the sentiment is pressured, but intraday buyers are showing renewed interest near the current support zone. The upcoming sessions could see sharp reactions if price tests either $15.87 or breaks $17.17. "Right now, I see range trades and quick pivots as the best approach for nimble traders," Turakhiya advises.

Mixed momentum signals as volatility meets technical boundaries

Momentum signals for CORZ are mixed. The daily MACD remains negative and signals ongoing bearish momentum, while the ADX indicates a weak trend. Oscillators diverge: the daily RSI is in sell territory, the CCI is oversold, and the Stoch RSI is neutral, with some intraday readings turning overbought. The BBP reflects continued dominance by sellers in the daily trend, despite intraday buying, and the AO is neutral without a strong signal. Today, the session opened with a moderate gap up from $15.46 to $15.91, and the current price is near the upper range of today's trading, showing moderate volatility and post-opening strength. Dynamic support is around $15.87, with resistance at $17.17 based on the SMA-50 and Ichimoku indicators.

Previously it was reported that Core Scientific Inc CORZ is trading below its key moving averages, with continued seller momentum and technical indicators like MACD, ADX, and RSI signaling oversold conditions and prevailing bearish sentiment. While today’s session shows some intraday buying interest near resistance and oversold oscillator levels, there remains a lack of confirmation for a sustained rebound and overall downside risk persists.

Source of Data: CORZ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.